Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 23, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	21	17	62	8	18	35
Market Cap Growth	-45.90%	-72.15%	627.66%	-51.77%	-50.18%	13.53%
Enterprise Value	17	12	53	5	10	27
Last Close Price	0.85	0.88	3.91	1.05	2.96	6.22
PS Ratio	31.22	24.39	133.15	37.56	68.97	48.92
PB Ratio	3.85	6.62	8.07	3.17	2.31	2.71
P/TBV Ratio	4.59	6.42	8.22	3.29	2.36	2.74
EV/Sales Ratio	32.24	17.46	114.33	21.58	39.44	37.19
Debt / Equity Ratio	0.02	0.04	0.02	0.06	0.01	0.01
Asset Turnover	0.07	0.11	0.08	0.04	0.02	0.09
Inventory Turnover	-	-	-	-	2.11	2.39
Quick Ratio	3.10	1.56	6.10	5.99	32.79	78.90
Current Ratio	3.68	2.32	7.18	8.04	35.96	81.18
Return on Equity (ROE)	-155.23%	-232.15%	-112.36%	-130.18%	-71.35%	-73.16%
Return on Assets (ROA)	-82.96%	-111.49%	-59.56%	-73.59%	-39.21%	-44.17%
Return on Capital Employed (ROCE)	-228.90%	-433.80%	-73.30%	-228.20%	-86.60%	-43.40%
Earnings Yield	-51.02%	-69.13%	-9.38%	-78.45%	-41.27%	-11.39%
FCF Yield	-41.17%	-60.84%	-8.09%	-69.63%	-27.98%	-11.28%
Buyback Yield / Dilution	-34.21%	-45.34%	-87.24%	-12.38%	-34.02%	-58.34%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q